Your browser is no longer supported. Please, upgrade your browser.
HOLX [NASD]
Hologic, Inc.
IndexS&P 500 P/E9.01 EPS (ttm)7.29 Insider Own1.10% Shs Outstand258.47M Perf Week0.12%
Market Cap16.70B Forward P/E15.59 EPS next Y4.21 Insider Trans-2.35% Shs Float255.98M Perf Month-10.80%
Income1.91B PEG3.83 EPS next Q1.11 Inst Own98.30% Short Float1.95% Perf Quarter-20.74%
Sales5.32B P/S3.14 EPS this Y671.70% Inst Trans0.88% Short Ratio2.29 Perf Half Y-11.01%
Book/sh14.68 P/B4.47 EPS next Y-44.76% ROA25.80% Target Price84.17 Perf Year23.97%
Cash/sh3.21 P/C20.45 EPS next 5Y2.35% ROE63.50% 52W Range49.19 - 85.00 Perf YTD-9.89%
Dividend- P/FCF9.22 EPS past 5Y56.10% ROI21.10% 52W High-23.49% Beta1.17
Dividend %- Quick Ratio2.10 Sales past 5Y6.90% Gross Margin68.90% 52W Low32.20% ATR1.92
Employees5814 Current Ratio2.60 Sales Q/Q103.40% Oper. Margin46.70% RSI (14)29.02 Volatility2.45% 2.57%
OptionableYes Debt/Eq0.73 EPS Q/Q553.00% Profit Margin35.90% Rel Volume0.87 Prev Close65.63
ShortableYes LT Debt/Eq0.71 EarningsApr 28 AMC Payout0.00% Avg Volume2.17M Price65.03
Recom1.80 SMA20-9.07% SMA50-9.87% SMA200-8.32% Volume1,434,835 Change-0.91%
Nov-20-20Downgrade Needham Buy → Hold
Nov-05-20Reiterated Needham Buy $78 → $88
Jun-30-20Upgrade Cowen Market Perform → Outperform $64
Jun-03-20Upgrade Raymond James Mkt Perform → Outperform $62
Apr-30-20Upgrade SVB Leerink Mkt Perform → Outperform $62
Apr-30-20Reiterated Needham Buy $52 → $60
Apr-07-20Upgrade Wells Fargo Equal Weight → Overweight $48
Mar-27-20Upgrade Morgan Stanley Underweight → Equal-Weight $40
Mar-27-20Downgrade Morgan Stanley Overweight → Equal-Weight $24
Jan-13-20Reiterated Needham Buy $57 → $62
Jan-08-20Initiated Wells Fargo Equal Weight $57
Jan-07-20Initiated Citigroup Buy $60
Jan-02-20Downgrade Evercore ISI Outperform → In-line
Sep-26-19Upgrade BofA/Merrill Neutral → Buy $54 → $59
Aug-01-19Reiterated Needham Buy $52 → $57
May-02-19Reiterated Needham Buy $50 → $52
Jan-31-19Reiterated Needham Buy $48 → $50
Jan-02-19Downgrade Morgan Stanley Equal-Weight → Underweight
Oct-09-18Initiated UBS Neutral
Sep-13-18Downgrade BofA/Merrill Buy → Neutral
May-08-21 06:45AM  
May-07-21 10:21AM  
May-04-21 07:09PM  
05:45PM  
11:30AM  
11:04AM  
Apr-29-21 09:46AM  
Apr-28-21 09:01PM  
05:15PM  
05:14PM  
04:01PM  
02:45PM  
Apr-27-21 08:56AM  
08:48AM  
Apr-26-21 10:17AM  
08:28AM  
Apr-23-21 11:40AM  
08:51AM  
Apr-20-21 08:30AM  
Apr-19-21 05:45PM  
12:10PM  
08:30AM  
Apr-15-21 08:30AM  
Apr-12-21 06:10PM  
05:45PM  
08:21AM  
07:51AM  
Apr-09-21 10:31AM  
09:00AM  
06:05AM  
Apr-08-21 10:36AM  
09:16AM  
08:00AM  
07:56AM  
07:17AM  
Apr-07-21 12:45PM  
09:59AM  
08:08AM  
Apr-06-21 11:50AM  
11:40AM  
11:40AM  
09:56AM  
Mar-31-21 07:17AM  
Mar-30-21 05:45PM  
03:00PM  
02:31PM  
12:19PM  
12:02PM  
11:43AM  
11:30AM  
07:01AM  
Mar-29-21 04:17PM  
Mar-26-21 10:43AM  
08:16AM  
Mar-25-21 09:10AM  
09:06AM  
07:43AM  
Mar-24-21 05:45PM  
11:06AM  
10:28AM  
Mar-23-21 01:27PM  
01:26PM  
08:56AM  
Mar-22-21 06:19PM  
12:34PM  
12:34PM  
10:29AM  
08:56AM  
08:03AM  
04:05AM  
Mar-18-21 05:45PM  
01:15PM  
11:40AM  
10:41AM  
10:40AM  
10:14AM  
09:59AM  
08:38AM  
07:48AM  
Mar-17-21 05:05PM  
08:23AM  
Mar-16-21 01:42PM  
12:20PM  
11:40AM  
10:23AM  
Mar-15-21 12:48PM  
09:06AM  
06:13AM  
Mar-12-21 05:45PM  
07:25AM  
Mar-11-21 11:50AM  
Mar-10-21 09:55AM  
09:24AM  
Mar-09-21 11:27AM  
09:17AM  
Mar-08-21 02:02PM  
08:01AM  
Mar-05-21 10:03AM  
08:18AM  
Mar-04-21 11:44PM  
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima quantitative viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. It has a collaboration with RadNet, Inc. to advance the use of artificial intelligence in breast health. Hologic, Inc. was founded in 1985 and is headquartered in Marlborough, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bebo Allison PSVP, Human ResourcesFeb 05Sale84.066,100512,77835,680Feb 09 04:18 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerFeb 04Option Exercise39.968,396335,50425,048Feb 08 04:56 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerFeb 04Sale84.318,396707,86716,652Feb 08 04:56 PM
Thornal Kevin RDiv. President, DiagnosticsDec 10Option Exercise38.6916,869652,65842,452Dec 14 04:44 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerDec 10Sale73.641,477108,75916,575Dec 14 04:41 PM
Thornal Kevin RDiv. President, DiagnosticsDec 10Sale73.9916,8691,248,21233,216Dec 14 04:44 PM
Griffin John M.General CounselNov 18Option Exercise39.9622,900915,084157,386Nov 20 04:12 PM
Griffin John M.General CounselNov 18Sale71.0822,9001,627,689134,486Nov 20 04:12 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerNov 17Option Exercise26.215,000131,05023,292Nov 19 04:10 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerNov 17Sale72.585,000362,90018,292Nov 19 04:10 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerNov 12Option Exercise26.216,542171,46625,127Nov 16 04:24 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerNov 12Sale70.606,542461,84618,585Nov 16 04:24 PM
GARRETT SCOTT TDirectorNov 09Option Exercise22.3511,146249,11362,531Nov 12 04:26 PM
Stamoulis ChristianaDirectorNov 04Option Exercise22.3511,146249,11350,538Nov 06 04:10 PM
Stamoulis ChristianaDirectorNov 04Sale74.0011,146824,80439,392Nov 06 04:10 PM
Oberton Karleen MarieChief Financial OfficerSep 22Option Exercise26.215,461143,13334,417Sep 23 04:21 PM
Oberton Karleen MarieChief Financial OfficerSep 21Option Exercise26.2115,000393,15043,956Sep 23 04:21 PM
Oberton Karleen MarieChief Financial OfficerSep 21Sale62.5015,000937,50028,956Sep 23 04:21 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerAug 03Option Exercise23.822,98671,12719,699Aug 05 05:49 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerAug 03Sale71.244,924350,81016,713Aug 05 05:49 PM
Valenti Peter J. IIIDivision Pres., Breast HealthJun 30Option Exercise26.2110,493275,02270,484Jul 02 04:04 PM
Valenti Peter J. IIIDivision Pres., Breast HealthJun 30Sale54.0710,493567,35759,991Jul 02 04:04 PM
Valenti Peter J. IIIDivision Pres., Breast HealthMay 22Option Exercise26.2110,493275,02270,484May 27 04:12 PM
Valenti Peter J. IIIDivision Pres., Breast HealthMay 22Sale51.8210,493543,77959,991May 27 04:12 PM
CRAWFORD SALLYDirectorMay 22Sale51.9931,9501,661,080126,847May 27 04:09 PM
Thornal Kevin RDiv. President, DiagnosticsMay 15Option Exercise26.0113,888361,22730,914May 19 04:09 PM
Thornal Kevin RDiv. President, DiagnosticsMay 15Sale51.5113,888715,42617,026May 19 04:09 PM
MACMILLAN STEPHEN PChairman, President and CEOMay 13Option Exercise22.29215,9964,814,5511,913,438May 15 04:17 PM
MACMILLAN STEPHEN PChairman, President and CEOMay 13Sale50.97190,9969,735,2571,722,442May 15 04:17 PM